Last reviewed · How we verify

NCT05549128

Transcutaneous Photobiomodulation on the Control of Chilhood Anxiety in Dental Care.

Status unknown NA Last updated 22 September 2022
What this trial tests

NA trial testing Photobiomodulation in Anxiety in 90 participants. Status unknown.

Timeline
10 November 2022
Primary endpoint
10 November 2023
20 March 2024

Quick facts

Lead sponsorUniversity of Nove de Julho
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment90
Start date10 November 2022
Primary completion10 November 2023
Estimated completion20 March 2024

Drugs / interventions tested

Conditions studied

Sponsor

University of Nove de Julho

Who can join

Adults 6 to 12, any sex, with Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to investigate whether photobiomodulation helps, collaborates, in the management of the child's anxiety in the dental office.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Photobiomodulation

Trials testing the same drug.

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other University of Nove de Julho trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05549128.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing